Calmer Co International Limited · ASX:CCO
Calmer Co International — The Calmer Co. International — Q4 FY2025 Earnings Presentation
15 slides from Calmer Co International's earnings presentation, Jul 31, 2025
Slide 1: Q4FY25 Results Presentation
For personal use only FOCUSING ON NATURAL PRODUCTS THAT PROMOTE CALMNESS, SUPPORT MIND & MUSCLE RELAXATION & IMPROVE SLEEP Q4FY25 RESULTS PRESENTATION Date: 31 July 2025
Slide 2: About The Calmer Co.
ABOUT THE CALMER CO. The Calmer Co. International Limited (ASX:CCO) is a fast-growing beverage company For personal use only leveraging a global opportunity in kava and other natural products that replace alcohol and support relaxation and sleep. Our products are delivered to consumers globally thro
Slide 3: Global kava root extract market size
The global kava root extract market size reached USD 1.6 Billion in For personal use only 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 14.11% during 2025-2033. Source: https://www.imarcgroup.com/kava-root-extract-market
Slide 4: Foundations for Scale & Success
FOUNDATIONS FOR SCALE & SUCCESS • Quality Certification Schemes e.g. GMP, Organic, Fair Trade • Public-Private Partnerships • Industry-led Associations & Codes of Practice For personal use only • Export Market Activation e.g. Amazon & DTC, Major Brand Wholesale, Retail • Government Support e.g. Mini
Slide 5: Foundations for Scale & Success
FOUNDATIONS FOR SCALE & SUCCESS For personal use only
Slide 6: Strategic Pillars
STRATEGIC PILLARS THE WORLD'S LEADING NATURAL RELAXATION COMPANY For personal use only Regional Sourcing Direct to Consumer Profitable & Wholesale (Bulk) & Innovation Inc. Amazon Scalable Retail Ingredients - PACIFIC ISLAND - AMAZON - MAJOR RETAIL - BEVERAGE & KAVA REGIONAL USA & AU SNACK BRANDS SOU
Slide 7: Regional Sourcing & Innovation
REGIONAL SOURCING & INNOVATION For personal use only Serves as a roadmap to establishing a globally competitive and sustainable kava supply chain that supports quality standards, innovation, regulatory improvements, and market expansion. The Calmer Co is well positioned to support a regional supply
Slide 8: Commercial Focus
COMMERCIAL FOCUS KAVA IN GROWTH CAPITALISE ON PILLAR 1 For personal use only • Growing US demand creating new customers and • Grow our core brands through effective and efficient consumers while ANZ markets in steady growth channels, utilising our innovation and agility advantage • Channels are evol
Slide 9: Q4 FY25
Q4 FY25 ▪ Platform for future profitable growth with improved GP and OP For personal use only ▪ US now 41% of Sales Mix > #1 by Q1FY26 ▪ Amazon forecasting 45% growth in kava / broader market expanding at over 16% CAGR ▪ +500 kava bars across the USA, reflecting the broad rise in demand and acceptan
Slide 10: Commercial Performance
COMMERCIAL PERFORMANCE For personal use only FY25 AMAZON WHOLESALE $1.9m $8m $607k $242k Revenues unaudited Q4 FY25 Q4 FY25 Revenue Revenue Revenue 6% 86% 28% 56% Vs Q3FY25 Vs FY24 Vs Q3FY25 Vs Q3FY25 Key Operating Insight Revenues Up 6% in Q4 vs Q3 US Market Growth Wholesale Continues to Grow All c
Slide 11: Amazon & D2C
AMAZON & D2C Online remains the key platforms for consumer engagement, education and conversions, with limited barriers to new products For personal use only Q4FY25 Amazon & D2C • Amazon Revenue up 28% to $607k • Improved marketing & portfolio • Identify valuable sub-categories & launch NPD (shots,
Slide 12: Strategic Retail
STRATEGIC RETAIL Key platform in raising kava-product category and brand awareness, increase trial, and establish on going usage in the mainstream. For personal use only Q4FY25 Retail • RRP increase implemented in both majors including wholesale price increase with Coles [4th and 11th June] • Succes
Slide 13: Wholesale
WHOLESALE Leveraging vertical integration advantage in a market with growing customers and limited suppliers or expertise For personal use only Q4FY25 Wholesale • Revenue up by 56% contributing now 13% of sales volume • First production & sale of high potency kava extract • Identified & formulated t
Slide 14: CEO Summary
CEO SUMMARY "Q4 was another strong step toward breakeven, with revenue up 6% to $1.9M. Amazon USA and wholesale channels delivered standout For personal use only growth, while retail remained solid with Woolworths orders commencing. We’ve completed our digital transition to the Acuity platform, sett
Slide 15: Q4 Results Webinar
For personal use only Q4 Results Webinar We invite all investors to join our quarterly results webinar. Register for the Q4 FY2025 Investor Webinar Thank you. Investor Hub To view this and other ASX releases please go to our Investor Hub. Join the conversation on Investor Hub
The Calmer Co. International — Q4 FY2025 Earnings Presentation on 6ix